Literature DB >> 9553812

Disruption of the E1 and E2 reading frames of HPV 16 in cervical carcinoma is associated with poor prognosis.

M Kalantari1, F Karlsen, G Kristensen, R Holm, B Hagmar, B Johansson.   

Abstract

The E1 and E2 reading frames of 158 cervical carcinoma samples containing human papillomavirus (HPV) 16 were mapped using polymerase chain reaction (PCR). The reading frames were amplified using primers spanning the entire genes. Of the analyzed samples, 23% showed no amplification with the E1 primers and 29% showed no amplification with the E2 primers. There was an overlap, but not complete identity, between the E1- and E2-disrupted groups. All E1- and E2-negative samples were further analyzed with primers spanning subsections of the E1 and E2 reading frames, which together covered the entire genes. Of the 35 samples negative for E1, 11 were positive in specific amplification of the 3' end of the E1 gene. Several different subsections of E2 could be amplified from most samples negative for the entire gene (37/46). Five classes of patterns were found, in which either all subsections of the E2 gene or subsections in the 5', middle, or 3' end were disrupted. Although a variable pattern of disruption/deletion in the E1-E2 area of the HPV 16 genome was found in cervical carcinoma, the 5' end disruption was the most common one in both E1 and E2. Patients with carcinomas showing disruptions in E1/E2 had a poorer survival than those without such changes, and E1 disruptions were the most important prognostically.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9553812     DOI: 10.1097/00004347-199804000-00009

Source DB:  PubMed          Journal:  Int J Gynecol Pathol        ISSN: 0277-1691            Impact factor:   2.762


  40 in total

1.  E2 proteins from high- and low-risk human papillomavirus types differ in their ability to bind p53 and induce apoptotic cell death.

Authors:  Joanna L Parish; Anna Kowalczyk; Hsin-Tien Chen; Geraldine E Roeder; Richard Sessions; Malcolm Buckle; Kevin Gaston
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

2.  Integrated human papillomavirus type 16 is frequently found in cervical cancer precursors as demonstrated by a novel quantitative real-time PCR technique.

Authors:  Panu Peitsaro; Bo Johansson; Stina Syrjänen
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

3.  Physical state and viral load as predictive biomarkersfor persistence and progression of HPV16-positive cervical lesions: results from a population based long-term prospective cohort study.

Authors:  Anna Manawapat; Frank Stubenrauch; Rainer Russ; Christian Munk; Susanne Kruger Kjaer; Thomas Iftner
Journal:  Am J Cancer Res       Date:  2012-02-15       Impact factor: 6.166

4.  Study of viral integration of HPV-16 in young patients with LSIL.

Authors:  G Gallo; M Bibbo; L Bagella; A Zamparelli; F Sanseverino; M R Giovagnoli; A Vecchione; A Giordano
Journal:  J Clin Pathol       Date:  2003-07       Impact factor: 3.411

5.  Increase of integration events and infection loads of human papillomavirus type 52 with lesion severity from low-grade cervical lesion to invasive cancer.

Authors:  Jo L K Cheung; T H Cheung; Julian W T Tang; Paul K S Chan
Journal:  J Clin Microbiol       Date:  2008-02-13       Impact factor: 5.948

6.  Methylation of human papillomavirus Type 16 CpG sites at E2-binding site 1 (E2BS1), E2BS2, and the Sp1-binding site in cervical cancer samples as determined by high-resolution melting analysis-PCR.

Authors:  Elise Jacquin; Alice Baraquin; Rajeev Ramanah; Xavier Carcopino; Adrien Morel; Séverine Valmary-Degano; Ignacio G Bravo; Silvia de Sanjosé; Didier Riethmuller; Christiane Mougin; Jean-Luc Prétet
Journal:  J Clin Microbiol       Date:  2013-07-17       Impact factor: 5.948

7.  Early integration of high copy HPV16 detectable in women with normal and low grade cervical cytology and histology.

Authors:  S-M A Kulmala; S M Syrjänen; U B Gyllensten; I P Shabalova; N Petrovichev; P Tosi; K J Syrjänen; B C Johansson
Journal:  J Clin Pathol       Date:  2006-02-16       Impact factor: 3.411

8.  Analysis of human papillomavirus type 16 (HPV16) DNA load and physical state for identification of HPV16-infected women with high-grade lesions or cervical carcinoma.

Authors:  Maëlle Saunier; Sylvain Monnier-Benoit; Frédéric Mauny; Véronique Dalstein; Jenny Briolat; Didier Riethmuller; Bernadette Kantelip; Elisabeth Schwarz; Christiane Mougin; Jean-Luc Prétet
Journal:  J Clin Microbiol       Date:  2008-09-17       Impact factor: 5.948

9.  Human papillomavirus DNA and e6/e7 mRNA status in relation to survival of patients treated for cervical squamous cell carcinoma.

Authors:  Ruth Holm; Irene Kraus; Hanne Skomedal; Anita Langerød; Gunnar B Kristensen; Heidi Lyng
Journal:  Open Virol J       Date:  2008-10-24

10.  Guidelines of the Italian Society for Virology on HPV testing and vaccination for cervical cancer prevention.

Authors:  Luisa Barzon; Colomba Giorgi; Franco M Buonaguro; Giorgio Palù
Journal:  Infect Agent Cancer       Date:  2008-12-16       Impact factor: 2.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.